Prognostic factors for the survival of patients with esophageal carcinoma in the US - The importance of tumor length and lymph node status

被引:327
作者
Eloubeidi, MA
Desmond, R
Arguedas, MR
Reed, CE
Wilcox, CM
机构
[1] Univ Alabama Birmingham, Dept Med, Div Gastroenterol & Hepatol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Biostat Unit, Birmingham, AL 35294 USA
[3] Med Univ S Carolina, Div Cardiothorac Surg, Charleston, SC 29425 USA
[4] Med Univ S Carolina, Ctr Comprehens Canc, Charleston, SC 29425 USA
关键词
esophageal carcinoma; survival; tumor length; lymph node status;
D O I
10.1002/cncr.10868
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The current TNM classification system does not consider tumor length or the number of lymph nodes in the staging and classification scheme for patients with esophageal carcinoma. Using data from the National Cancer Institute SEER Program, the authors explored the effect of tumor length and number of positive lymph nodes on survival in patients with esophageal carcinoma. METHODS. Patients with esophageal adenocarcinoma or squamous cell carcinoma were subgrouped according to historic stage with localized, regional, or distant disease. Demographic factors (age at diagnosis, race, and gender) and tumor characteristics (morphology, histologic grade, tumor length, primary site, depth of invasion, number of positive lymph nodes, proportion of positive lymph nodes dissected, and distant metastatic sites) were examined. RESULTS. Overall factors that were associated with an increased mortality risk included increasing age at diagnosis, black race versus white race, histologic grade, primary tumor site in the lower esophagus and abdomen versus upper regions, and increasing depth of invasion. Among patients with regional disease, the number of positive lymph nodes (greater than or equal to 5 vs. < 5) was related to an increasing risk (hazard ratio [HR], 1.29; 95% confidence interval [95%CI], 1.06-1.56). The proportion of positive lymph nodes compared with the number of lymph nodes dissected conferred an increased risk (HR, 1.63; 95%.CI, 1.26-2.11). Among patients with distant disease, sites other than distant lymph nodes implied an increased mortality risk (HR, 1.37; 95%CI, 1.37-1.65). Tumor length was an independent predictor of mortality when controlling for depth of invasion in patients with localized disease (HR, 1.15; 95%CI, 1.08-1.21). CONCLUSIONS. Tumor length, the number of involved lymph nodes, and the ratio of positive lymph nodes are important prognostic factors for survival in patients with esophageal carcinoma. A revised TNM classification system for patients with esophageal carcinoma might consider adding tumor length and number of positive lymph nodes as two important prognostic factors.
引用
收藏
页码:1434 / 1443
页数:10
相关论文
共 50 条
  • [21] The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients
    Singh, Dharmendra
    Mandal, Avik
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (03) : 839 - 848
  • [22] The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients
    Dharmendra Singh
    Avik Mandal
    Breast Cancer Research and Treatment, 2020, 184 : 839 - 848
  • [23] The Prognostic Impact of Extracapsular Lymph Node Involvement in Esophageal Squamous Cell Carcinoma
    Lin, Chih-Ming
    Tu, Cheng-Che
    Yeh, Yi-Chen
    Hsu, Po-Kuei
    Chien, Ling-I.
    Huang, Chien-Sheng
    Wu, Yu-Chung
    Hsu, Han-Shui
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (08) : 3071 - 3082
  • [24] Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma
    Smith, Franz O.
    Yue, Binglin
    Marzban, Suroosh S.
    Walls, Brooke L.
    Carr, Michael
    Jackson, Ryan S.
    Puleo, Christopher A.
    Padhya, Tapan
    Cruse, C. Wayne
    Gonzalez, Ricardo J.
    Sarnaik, Amod A.
    Schell, Michael J.
    DeConti, Ronald C.
    Messina, Jane L.
    Sondak, Vernon K.
    Zager, Jonathan S.
    CANCER, 2015, 121 (18) : 3252 - 3260
  • [25] The prognostic significance of lymph node size in patients with squamous esophageal cancer
    Dhar, DK
    Tachibana, M
    Kinukawa, N
    Riruke, M
    Kohno, H
    Little, AG
    Nagasue, N
    ANNALS OF SURGICAL ONCOLOGY, 2002, 9 (10) : 1010 - 1016
  • [26] The prognostic significance of lymph node size in patients with squamous esophageal cancer
    Dipok Kumar Dhar
    Mitsuo Tachibana
    Naoko Kinukawa
    Maruyama Riruke
    Hitoshi Kohno
    Alex G. Little
    Naofumi Nagasue
    Annals of Surgical Oncology, 2002, 9 : 1010 - 1016
  • [27] Impact of Tumor Site on Lymph Node Status and Survival in Colon Cancer
    Xie, Yayun
    Huang, Yu
    Ruan, Qi
    Wang, Haolu
    Liang, Xiaowen
    Hu, Zhiqian
    Li, Xinxing
    JOURNAL OF CANCER, 2019, 10 (11): : 2376 - 2383
  • [28] Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma
    Luo, H.
    Cui, Y. Y.
    Zhang, J. G.
    Sun, Y. N.
    Zheng, X. L.
    Yang, C. L.
    Ye, K.
    Ge, H.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07) : 889 - 898
  • [29] Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Yun, Jae Kwang
    Kim, Youngwoong
    Lee, Geun Dong
    Choi, Sehoon
    Kim, Yong-Hee
    Kim, Dong Kwan
    Park, Seung-Il
    Kim, Hyeong Ryul
    CANCER MEDICINE, 2022, 11 (19): : 3623 - 3632
  • [30] Concordance of HER2 Status in Primary Tumour and Lymph Node Metastases in Patients with Esophageal Carcinoma
    Koenig, Alexandra M.
    Reeh, Matthias
    Dancau, Ana-Maria
    Rathjens, Merrit
    Gros, Stephanie
    Uzunoglu, Faik G.
    Bockhorn, Maximilian
    Simon, Ronald
    Sauter, Guido
    Marx, Andreas
    Izbicki, Jakob R.
    ANTICANCER RESEARCH, 2013, 33 (11) : 4975 - 4982